BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Prognosis
11 results:

  • 1. Construction of an immune-related risk score signature for gastric cancer based on multi-omics data.
    Wang Y; Huang W; Zheng S; Wang L; Zhang L; Pei X
    Sci Rep; 2024 Jan; 14(1):1422. PubMed ID: 38228846
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of key genes associated with poor prognosis and neoplasm staging in gastric cancer.
    Wang S; Yang X; Liu C; Hu J; Yan M; Ding C; Fu Y
    Medicine (Baltimore); 2023 Oct; 102(40):e35111. PubMed ID: 37800754
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Senescence-related genes define prognosis, immune contexture, and pharmacological response in gastric cancer.
    Shen X; Wang M; Chen W; Xu Y; Zhou Q; Zhu T; Wang G; Cai S; Han Y; Xu C; Wang W; Meng L; Sun H
    Aging (Albany NY); 2023 Feb; 15(8):2891-2905. PubMed ID: 37100457
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. pdgfrb is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Liu B; Xiao X; Lin Z; Lou Y; Zhao L
    Cancer Biomark; 2022; 34(2):251-264. PubMed ID: 34958001
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Discovery of Prognostic Signature Genes for Overall Survival Prediction in gastric cancer.
    Meng C; Xia S; He Y; Tang X; Zhang G; Zhou T
    Comput Math Methods Med; 2020; 2020():5479279. PubMed ID: 32908579
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors.
    Ibrahim A; Chopra S
    Arch Pathol Lab Med; 2020 May; 144(5):655-660. PubMed ID: 31169996
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (pdgfrs) in gastric cancer: A systematic review and meta-analysis.
    Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
    Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes.
    Kwon CH; Kim YK; Lee S; Kim A; Park HJ; Choi Y; Won YJ; Park DY; Lauwers GY
    Histopathology; 2018 Mar; 72(4):556-568. PubMed ID: 28873240
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic impact of major receptor tyrosine kinase expression in gastric cancer.
    Kurokawa Y; Matsuura N; Kawabata R; Nishikawa K; Ebisui C; Yokoyama Y; Shaker MN; Hamakawa T; Takahashi T; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S584-90. PubMed ID: 24743909
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma.
    Mayr M; Becker K; Schulte N; Belle S; Hofheinz R; Krause A; Schmid RM; Röcken C; Ebert MP
    BMC Cancer; 2012 Dec; 12():587. PubMed ID: 23228190
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Gastrointestinal gastric tumor (GIST) as a cause of massive hemorrhage from the upper digestive tract].
    Djukić V; Karamarković A; Mijatović S; Micev M; Bumbasirević V; Djurović M; Stepić D; Jeremić V; Popović N; Sijacki A; Krsić S; Gregorić P
    Acta Chir Iugosl; 2007; 54(1):169-71. PubMed ID: 17633880
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.